154 related articles for article (PubMed ID: 30550953)
1. Targeting STATs in neuroinflammation: The road less traveled!
Nabavi SM; Ahmed T; Nawaz M; Devi KP; Balan DJ; Pittalà V; Argüelles-Castilla S; Testai L; Khan H; Sureda A; de Oliveira MR; Vacca RA; Xu S; Yousefi B; Curti V; Daglia M; Sobarzo-Sánchez E; Filosa R; Nabavi SF; Majidinia M; Dehpour AR; Shirooie S
Pharmacol Res; 2019 Mar; 141():73-84. PubMed ID: 30550953
[TBL] [Abstract][Full Text] [Related]
2. Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways.
Guo C; Yang L; Wan CX; Xia YZ; Zhang C; Chen MH; Wang ZD; Li ZR; Li XM; Geng YD; Kong LY
Phytomedicine; 2016 Dec; 23(13):1629-1637. PubMed ID: 27823627
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics.
Ivanenkov YA; Balakin KV; Lavrovsky Y
Mini Rev Med Chem; 2011 Jan; 11(1):55-78. PubMed ID: 21034406
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
5. Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/JAK/STAT signal transduction pathway in patients with cancer.
Roxburgh CS; McMillan DC
Transl Res; 2016 Jan; 167(1):61-6. PubMed ID: 26432924
[TBL] [Abstract][Full Text] [Related]
6. JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases.
Gao Q; Liang X; Shaikh AS; Zang J; Xu W; Zhang Y
Curr Drug Targets; 2018; 19(5):487-500. PubMed ID: 27928945
[TBL] [Abstract][Full Text] [Related]
7. Sophoraflavanone G from Sophora alopecuroides inhibits lipopolysaccharide-induced inflammation in RAW264.7 cells by targeting PI3K/Akt, JAK/STAT and Nrf2/HO-1 pathways.
Guo C; Yang L; Luo J; Zhang C; Xia Y; Ma T; Kong L
Int Immunopharmacol; 2016 Sep; 38():349-56. PubMed ID: 27351825
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-κB inhibition.
Park SY; Kim YH; Park G
Neurosci Lett; 2015 Nov; 609():129-36. PubMed ID: 26472707
[TBL] [Abstract][Full Text] [Related]
9. Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases.
Szelag M; Wesoly J; Bluyssen HA
Curr Protein Pept Sci; 2016; 17(2):135-46. PubMed ID: 26521960
[TBL] [Abstract][Full Text] [Related]
10. Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors.
Welsch K; Holstein J; Laurence A; Ghoreschi K
Eur J Immunol; 2017 Jul; 47(7):1096-1107. PubMed ID: 28555727
[TBL] [Abstract][Full Text] [Related]
11. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
Yang X; Tang Z; Zhang P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
[TBL] [Abstract][Full Text] [Related]
12. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
13. Comparative screening and validation as a novel tool to identify STAT-specific inhibitors.
Szeląg M; Czerwoniec A; Wesoly J; Bluyssen HA
Eur J Pharmacol; 2014 Oct; 740():417-20. PubMed ID: 25183399
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.
Szelag M; Piaszyk-Borychowska A; Plens-Galaska M; Wesoly J; Bluyssen HA
Oncotarget; 2016 Jul; 7(30):48788-48812. PubMed ID: 27166190
[TBL] [Abstract][Full Text] [Related]
15. Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants.
Amani H; Ajami M; Nasseri Maleki S; Pazoki-Toroudi H; Daglia M; Tsetegho Sokeng AJ; Di Lorenzo A; Nabavi SF; Devi KP; Nabavi SM
Biochimie; 2017 Nov; 142():63-79. PubMed ID: 28807562
[TBL] [Abstract][Full Text] [Related]
16. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
17. Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthma.
Vale K
Future Med Chem; 2016; 8(4):405-19. PubMed ID: 26934038
[TBL] [Abstract][Full Text] [Related]
18. JAK inhibitors in 2019, synthetic review in 10 points.
Muller R
Eur J Intern Med; 2019 Aug; 66():9-17. PubMed ID: 31178258
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of JAK/STAT pathway modulation in mood disorders.
Shariq AS; Brietzke E; Rosenblat JD; Pan Z; Rong C; Ragguett RM; Park C; McIntyre RS
Rev Neurosci; 2018 Dec; 30(1):1-7. PubMed ID: 29902157
[TBL] [Abstract][Full Text] [Related]
20. Cobalt(II) β-ketoaminato complexes as novel inhibitors of neuroinflammation.
Madeira JM; Beloukhina N; Boudreau K; Boettcher TA; Gurley L; Walker DG; McNeil WS; Klegeris A
Eur J Pharmacol; 2012 Feb; 676(1-3):81-8. PubMed ID: 22173130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
